- Patent Title: Methods of manufacturing a high molecular weight heparin compound
-
Application No.: US17743154Application Date: 2022-05-12
-
Publication No.: US11712447B2Publication Date: 2023-08-01
- Inventor: Li Fu , Zhenyu Wang , Jessica Pax
- Applicant: NexEos Diagnostics, Inc.
- Applicant Address: US PA Pottstown
- Assignee: NexEos Diagnostics, Inc.
- Current Assignee: NexEos Diagnostics, Inc.
- Current Assignee Address: US PA Pottstown
- Agency: DLA Piper LLP (US)
- Main IPC: A61K31/727
- IPC: A61K31/727 ; A61K47/02 ; A61P7/02 ; A61K9/08

Abstract:
A method of manufacturing a high molecular weight heparin (HMWH) compound is disclosed. The method comprises dissolving heparin to form a heparin solution and fractionating the heparin solution via tangential flow filtration (TFF) using a membrane with a molecular weight cut off (MWCO) between about 8 kDa and about 12 kDa. The TFF yields a retentate comprising fractionated heparin with a weight average molecular weight of about 20 kDa or greater, i.e., a high molecular weight heparin compound. A substantial proportion of heparin chains in the fractionated heparin may have a high molecular weight, e.g., 50% of the heparin chains or greater may have a molecular weight of 20 kDa or greater.
Public/Granted literature
- US20220362283A1 METHODS OF MANUFACTURING A HIGH MOLECULAR WEIGHT HEPARIN COMPOUND Public/Granted day:2022-11-17
Information query
IPC分类: